{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:08:13Z","timestamp":1789992493317,"version":"4.0.1"},"reference-count":131,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>In laryngeal squamous cell carcinoma, hypoxia plays a major role in growth, spread, and treatment resistance. HIF-1\u03b1, VEGF, and GLUT1 are three linked biomarkers that show different aspects of this response. Low oxygen can be sensed by HIF-1\u03b1, and it follows up by activating genes that help with the survival of the tumour cells. VEGF helps to form new blood vessels, while GLUT1 increases the uptake of glucose and maintains the production of energy even when there is a lack of oxygen. Tissue and serum studies have reported higher levels of these biomarkers in malignant than in benign or normal samples, together with associations with adverse clinicopathological features. However, their diagnostic and prognostic utility remains exploratory because clinically validated thresholds, diagnostic performance measures, and independent prospective validation remain limited. Combined assessment of these biomarkers may provide complementary information on hypoxic signalling, angiogenesis and metabolic adaptation, although its diagnostic or prognostic superiority over individual biomarkers has not yet been established. However, serum measurements can be influenced by pre-analytical and systemic factors. So, in order for these biomarkers to advance enough to be used in clinical laryngology, large multicenter studies and a standardized set of testing methods will be necessary.<\/jats:p>","DOI":"10.3390\/biomedicines14092103","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:25:43Z","timestamp":1789986343000},"page":"2103","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Molecular Basis and Biomarker Potential of the HIF-1\u03b1\u2013VEGF\u2013GLUT1 Hypoxia Axis in Laryngeal Squamous Cell Carcinoma"],"prefix":"10.3390","volume":"14","author":[{"given":"Wojciech","family":"Domka","sequence":"first","affiliation":[{"name":"Department of Otolaryngology, Faculty of Medicine, Collegium Medicum, University of Rzesz\u00f3w, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Misio\u0142ek","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology and Oncological Laryngology in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4115-7779","authenticated-orcid":false,"given":"Daniel Roshan","family":"Justin Raj","sequence":"additional","affiliation":[{"name":"English Division Science Club, Medical College of The Rzesz\u00f3w University, 35-310 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5557-5464","authenticated-orcid":false,"given":"Dorota","family":"Bartusik-Aebisher","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and General Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzesz\u00f3w, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0658-5471","authenticated-orcid":false,"given":"Angelika","family":"My\u015bliwiec","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and General Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzesz\u00f3w, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2661-6570","authenticated-orcid":false,"given":"David","family":"Aebisher","sequence":"additional","affiliation":[{"name":"Department of Photomedicine and Physical Chemistry, Faculty of Medicine, Collegium Medicum, University of Rzesz\u00f3w, 35-959 Rzesz\u00f3w, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Verro, B., Saraniti, C., Carlisi, D., Chiesa-Estomba, C., Maniaci, A., Lechien, J.R., Mayo, M., Fakhry, N., and Lauricella, M. (2023). Biomarkers in Laryngeal Squamous Cell Carcinoma: The Literature Review. Cancers, 15.","DOI":"10.3390\/cancers15205096"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Falco, M., Tammaro, C., Takeuchi, T., Cossu, A.M., Scafuro, G., Zappavigna, S., Itro, A., Addeo, R., Scrima, M., and Lombardi, A. (2022). Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem. Cancers, 14.","DOI":"10.3390\/cancers14071716"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/00016489.2022.2085885","article-title":"Concentration of hypoxia-inducible factor-1, glucose transporter 1 and vascular endothelial growth factor in tissue samples and serum in patients with primary laryngeal carcinoma","volume":"142","author":"Bronikowska","year":"2022","journal-title":"Acta Otolaryngol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Qannita, R.A., Alalami, A.I., Harb, A.A., Aleidi, S.M., Taneera, J., Abu-Gharbieh, E., El-Huneidi, W., Saleh, M.A., Alzoubi, K.H., and Semreen, M.H. (2024). Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation. Pharmaceuticals, 17.","DOI":"10.3390\/ph17020195"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3892\/ol.2012.941","article-title":"Expression and significance of hypoxia-inducible factor-1\u03b1 and glucose transporter-1 in laryngeal carcinoma","volume":"5","author":"Wu","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_6","first-page":"330","article-title":"Expression of hypoxia inducible factor-1\u03b1 and correlated target genes in human laryngeal carcinoma","volume":"47","author":"Xu","year":"2012","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3892\/mco.2012.17","article-title":"Molecular-targeted therapy hypoxia in head and neck squamous cell carcinoma patients","volume":"1","author":"Adachi","year":"2013","journal-title":"Mol. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"708974","DOI":"10.5402\/2012\/708974","article-title":"Hypoxia in head and neck squamous cell carcinoma","volume":"2012","author":"Li","year":"2012","journal-title":"ISRN Otolaryngol."},{"key":"ref_9","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"21513","DOI":"10.1016\/S0021-9258(20)80571-7","article-title":"Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia","volume":"268","author":"Wang","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","article-title":"Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension","volume":"92","author":"Wang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"7987","DOI":"10.1073\/pnas.95.14.7987","article-title":"Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway","volume":"95","author":"Huang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia","volume":"22","author":"Berra","year":"2003","journal-title":"EMBO J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1101\/gad.991402","article-title":"FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor","volume":"16","author":"Lando","year":"2002","journal-title":"Genes Dev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/bj20021162","article-title":"Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the beta-carbon of asparagine-803","volume":"367","author":"McNeill","year":"2002","journal-title":"Biochem J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1182\/blood.V89.2.503","article-title":"Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: Evidence against a regulatory role for Src kinase","volume":"89","author":"Gleadle","year":"1997","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1101\/gad.12.2.149","article-title":"Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha","volume":"12","author":"Iyer","year":"1998","journal-title":"Genes Dev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1128\/MCB.16.9.4604","article-title":"Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1","volume":"16","author":"Forsythe","year":"1996","journal-title":"Mol. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3748\/wjg.v10.i8.1082","article-title":"Hypoxia-inducible factor-1 in tumour angiogenesis","volume":"10","author":"Shi","year":"2004","journal-title":"World J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"23757","DOI":"10.1016\/S0021-9258(17)31580-6","article-title":"Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1","volume":"269","author":"Semenza","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gde.2009.10.009","article-title":"HIF-1: Upstream and downstream of cancer metabolism","volume":"20","author":"Semenza","year":"2010","journal-title":"Curr. Opin. Genet Dev."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1172\/JCI67230","article-title":"HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations","volume":"123","author":"Semenza","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_29","first-page":"6669","article-title":"HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors","volume":"61","author":"Sowter","year":"2001","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1128\/MCB.00166-09","article-title":"Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains","volume":"29","author":"Bellot","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"16369","DOI":"10.1073\/pnas.1113483108","article-title":"Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation","volume":"108","author":"Wong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","first-page":"707","article-title":"Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma","volume":"21","author":"Ishikawa","year":"2009","journal-title":"Oncol. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrc3726","article-title":"Hypoxia and the extracellular matrix: Drivers of tumour metastasis","volume":"14","author":"Gilkes","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"549412","DOI":"10.1155\/2015\/549412","article-title":"Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies","volume":"2015","author":"Zimna","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1177\/1947601911423654","article-title":"Hypoxia-induced angiogenesis: Good and evil","volume":"2","author":"Krock","year":"2011","journal-title":"Genes Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: Role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1101\/sqb.2011.76.010678","article-title":"Regulation of metabolism by hypoxia-inducible factor 1","volume":"76","author":"Semenza","year":"2011","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1074\/jbc.M010144200","article-title":"Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1677\/joe.1.05599","article-title":"Induction of glucose transporter 1 expression through hypoxia-inducible factor 1alpha under hypoxic conditions in trophoblast-derived cells","volume":"183","author":"Hayashi","year":"2004","journal-title":"J. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1165\/ajrcmb.21.6.3751","article-title":"Hypoxia upregulates activity and expression of the glucose transporter GLUT1 in alveolar epithelial cells","volume":"21","author":"Ouiddir","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1101\/gad.1529107","article-title":"The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis","volume":"21","author":"Lum","year":"2007","journal-title":"Genes Dev."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Nagao, A., Kobayashi, M., Koyasu, S., Chow, C.C.T., and Harada, H. (2019). HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020238"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"19253","DOI":"10.1074\/jbc.272.31.19253","article-title":"Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension","volume":"272","author":"Jiang","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5367","DOI":"10.1073\/pnas.082117899","article-title":"Structural basis for recruitment of CBP\/p300 by hypoxia-inducible factor-1 alpha","volume":"99","author":"Freedman","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1073\/pnas.181341498","article-title":"HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation","volume":"98","author":"Yu","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1128\/MCB.25.15.6415-6426.2005","article-title":"Coordinate regulation of the oxygen-dependent degradation domains of hypoxia-inducible factor 1 alpha","volume":"25","author":"Chan","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.94.15.8104","article-title":"Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth","volume":"94","author":"Maxwell","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"32529","DOI":"10.1074\/jbc.271.51.32529","article-title":"Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1","volume":"271","author":"Semenza","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3892\/ol.2013.1321","article-title":"Expression and significance of hypoxia-inducible factor-1\u03b1 and MDR1\/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells","volume":"6","author":"Xie","year":"2013","journal-title":"Oncol. Lett."},{"key":"ref_50","first-page":"3708","article-title":"Expression of glucose transporter-1, hypoxia inducible factor-1\u03b1 and beclin-1 in head and neck cancer and their implication","volume":"11","author":"Lin","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/coa.13789","article-title":"Serum hypoxia-inducible factor-2: A candidate prognostic biomarker for laryngeal cancer","volume":"46","author":"Eskiizmir","year":"2021","journal-title":"Clin. Otolaryngol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.6823562","article-title":"Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid","volume":"219","author":"Senger","year":"1983","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1042\/bst0311171","article-title":"VEGF signalling: Integration and multi-tasking in endothelial cell biology","volume":"31","author":"Zachary","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"Holmes","year":"2007","journal-title":"Cell Signal"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/00016489950180711","article-title":"Vascular endothelial growth factor (VEGF) and microvessel density in squamous cell carcinomas of the larynx: An immunohistochemical study","volume":"119","author":"Neuchrist","year":"1999","journal-title":"Acta Otolaryngol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s004280050037","article-title":"Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma","volume":"436","author":"Sawatsubashi","year":"2000","journal-title":"Virchows Arch."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cncr.22432","article-title":"Prognostic significance of vascular endothelial growth factor protein levels in T1-2 N0 laryngeal cancer treated with primary radiation therapy","volume":"109","author":"Parikh","year":"2007","journal-title":"Cancer"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s004059900208","article-title":"Serum levels of vascular endothelial growth factor in patients with head and neck cancer","volume":"257","author":"Riedel","year":"2000","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/hed.10163","article-title":"Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma","volume":"24","author":"Teknos","year":"2002","journal-title":"Head Neck"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjoto.2006.06.015","article-title":"Serum vascular endothelial growth factor in patients with pharyngeal and laryngeal squamous cell carcinoma treated with radiotherapy","volume":"28","author":"Gisterek","year":"2007","journal-title":"Am. J. Otolaryngol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1432-1033.1994.tb18550.x","article-title":"Facilitative glucose transporters","volume":"219","author":"Mueckler","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev.nu.16.070196.001315","article-title":"Structure, function, and regulation of the mammalian facilitative glucose transporter gene family","volume":"16","author":"Olson","year":"1996","journal-title":"Annu. Rev. Nutr."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00109-015-1307-x","article-title":"Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate\/H(+) symporters","volume":"94","author":"Marchiq","year":"2016","journal-title":"J. Mol. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.5487\/TR.2016.32.3.177","article-title":"Targeting Cancer Metabolism\u2014Revisiting the Warburg Effects","volume":"32","author":"Tran","year":"2016","journal-title":"Toxicol. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"10732748211041243","DOI":"10.1177\/10732748211041243","article-title":"Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy","volume":"28","author":"Kozal","year":"2021","journal-title":"Cancer Control"},{"key":"ref_71","first-page":"928","article-title":"Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix","volume":"7","author":"Airley","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s13277-014-2838-4","article-title":"Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1\u03b1 expression, tumor invasiveness, and patient prognosis","volume":"36","author":"Starska","year":"2015","journal-title":"Tumour Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1096\/fj.201802675R","article-title":"Exosomes from activated hepatic stellate cells contain GLUT1 and PKM2: A role for exosomes in metabolic switch of liver nonparenchymal cells","volume":"33","author":"Wan","year":"2019","journal-title":"FASEB J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"cm8","DOI":"10.1126\/stke.4072007cm8","article-title":"Hypoxia-inducible factor 1 (HIF-1) pathway","volume":"2007","author":"Semenza","year":"2007","journal-title":"Sci. STKE"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jcb.21579","article-title":"VEGF in biological control","volume":"102","author":"Breen","year":"2007","journal-title":"J. Cell Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1044-579X(02)00103-7","article-title":"The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis","volume":"13","author":"Pugh","year":"2003","journal-title":"Semin Cancer Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gendis.2016.11.003","article-title":"The role of hypoxia-inducible factors in tumor angiogenesis and cell metabolism","volume":"4","author":"Lv","year":"2016","journal-title":"Genes Dis."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3892\/mmr.2012.1075","article-title":"Regulation of glucose transporter protein-1 and vascular endothelial growth factor by hypoxia inducible factor 1\u03b1 under hypoxic conditions in Hep-2 human cells","volume":"6","author":"Xu","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"ref_79","first-page":"389","article-title":"Expression of HIF-1alpha and VEGF in human laryngeal carcinoma and its relationship with angiogenes","volume":"28","author":"Qiu","year":"2014","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1124\/mol.107.038851","article-title":"Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia","volume":"73","author":"Yeh","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Du, W., Ren, L., Hamblin, M.H., and Fan, Y. (2021). Endothelial Cell Glucose Metabolism and Angiogenesis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9020147"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14304\/SURYA.JPR.V5N1.4","article-title":"Regulation of glycolysis in head and neck squamous cell carcinoma","volume":"5","author":"Kumar","year":"2017","journal-title":"Postdoc J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.2147\/OTT.S300423","article-title":"Effect of GLUT1 Inhibition and Autophagy Modulation on the Growth and Migration of Laryngeal Carcinoma Stem Cells Under Hypoxic and Low-Glucose Conditions","volume":"14","author":"Chen","year":"2021","journal-title":"Onco Targets Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"34709","DOI":"10.18632\/oncotarget.16671","article-title":"In vivo evaluation of the effects of simultaneous inhibition of GLUT-1 and HIF-1\u03b1 by antisense oligodeoxynucleotides on the radiosensitivity of laryngeal carcinoma using micro 18F-FDG PET\/CT","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1111\/jcmm.17303","article-title":"Effect of Glut-1 and HIF-1\u03b1 double knockout by CRISPR\/CAS9 on radiosensitivity in laryngeal carcinoma via the PI3K\/Akt\/mTOR pathway","volume":"26","author":"Bao","year":"2022","journal-title":"J. Cell Mol. Med."},{"key":"ref_86","first-page":"1114","article-title":"Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma","volume":"21","author":"Li","year":"2007","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12032-015-0716-6","article-title":"Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT","volume":"33","author":"Zuo","year":"2016","journal-title":"Med. Oncol."},{"key":"ref_88","first-page":"3938","article-title":"Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: An in vitro study","volume":"7","author":"Xu","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Walz, J.M., Boehringer, D., Deissler, H.L., Faerber, L., Goepfert, J.C., Heiduschka, P., Kleeberger, S.M., Klettner, A., Krohne, T.U., and Schneiderhan-Marra, N. (2016). Pre-Analytical Parameters Affecting Vascular Endothelial Growth Factor Measurement in Plasma: Identifying Confounders. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0145375"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"625","DOI":"10.21037\/tlcr.2017.09.13","article-title":"Ensuring sample quality for blood biomarker studies in clinical trials: A multicenter international study for plasma and serum sample preparation","volume":"6","author":"Kong","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"10732748221144457","DOI":"10.1177\/10732748221144457","article-title":"The Expression of Hypoxia-Related Biomarkers: A Significance of HIF-1\u03b1 C1772T Polymorphism as Predictor of Laryngeal Carcinoma Relapse","volume":"29","author":"Folic","year":"2022","journal-title":"Cancer Control"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3858\/emm.2009.41.1.007","article-title":"Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1beta, but not HIF-2alpha, in gastric cancer","volume":"41","author":"Song","year":"2009","journal-title":"Exp. Mol. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ijc.11068","article-title":"Expression of hypoxia-inducible factor-1alpha is associated with tumor vascularization in human colorectal carcinoma","volume":"105","author":"Kuwai","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02893436","article-title":"Clinicopathological significance and linkage of the distribution of HIF-1alpha and GLUT-1 in human primary colorectal cancer","volume":"13","author":"Wincewicz","year":"2007","journal-title":"Pathol. Oncol. Res."},{"key":"ref_95","first-page":"1359","article-title":"Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis","volume":"30","author":"Sun","year":"2007","journal-title":"Int. J. Oncol."},{"key":"ref_96","first-page":"386","article-title":"Significance of hypoxia in uterine cervical cancer. Multicentre study","volume":"28","author":"Markowska","year":"2007","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3748\/wjg.v11.i11.1705","article-title":"Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: Impact on neovascularization and survival","volume":"11","author":"Huang","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2353\/ajpath.2009.080596","article-title":"GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis","volume":"174","author":"Amann","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_99","first-page":"399","article-title":"Expressions and Significance of ALDH1, HIF-1\u03b1 and VEGF in Laryngeal Squamous Cell Carcinoma","volume":"48","author":"Zhao","year":"2017","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref_100","first-page":"265","article-title":"The expression and correlation of HMGB1 and VEGF protein in laryngeal squamous cell carcinoma","volume":"25","author":"Liu","year":"2011","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/00016489950181846","article-title":"Angiogenic factors in laryngeal carcinomas: Do they have prognostic relevance?","volume":"119","author":"Burian","year":"1999","journal-title":"Acta Otolaryngol."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Schl\u00fcter, A., Weller, P., Kanaan, O., Nel, I., Heusgen, L., H\u00f6ing, B., Ha\u00dfkamp, P., Zander, S., Mandapathil, M., and Dominas, N. (2018). CD31 and VEGF are prognostic biomarkers in early-stage, but not in late-stage, laryngeal squamous cell carcinoma. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4180-5"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/lary.20483","article-title":"Prognostic significance of vascular endothelial growth factor-C expression and lymphatic vessel density in supraglottic squamous cell carcinoma","volume":"119","author":"Baek","year":"2009","journal-title":"Laryngoscope"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Marioni, G., Franz, L., Ottaviano, G., Contro, G., Tealdo, G., Carli, A., Frigo, A.C., Nicolai, P., and Alessandrini, L. (2020). Prognostic Significance of CD105- and CD31-Assessed Microvessel Density in Paired Biopsies and Surgical Samples of Laryngeal Carcinoma. Cancers, 12.","DOI":"10.3390\/cancers12082059"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"321","DOI":"10.14639\/0392-100X-588","article-title":"Macrophageal infiltration and microvessel density in laryngeal carcinoma: Study of 52 cases","volume":"35","author":"Popov","year":"2015","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"C1172","DOI":"10.1152\/ajpcell.1996.271.4.C1172","article-title":"Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension","volume":"271","author":"Jiang","year":"1996","journal-title":"Am. J. Physiol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2005.06.037","article-title":"Influence of oxygen concentration and pH on expression of hypoxia induced genes","volume":"76","author":"Hao","year":"2005","journal-title":"Radiother. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.radonc.2007.04.028","article-title":"Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH","volume":"83","author":"Alsner","year":"2007","journal-title":"Radiother. Oncol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/hed.23620","article-title":"HIF-1\u03b1 and CA-IX as predictors of locoregional control for determining the optimal treatment modality for early-stage laryngeal carcinoma","volume":"37","author":"Kwon","year":"2015","journal-title":"Head Neck"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/coa.13540","article-title":"Biological tumor markers associated with local control after primary radiotherapy in laryngeal cancer: A systematic review","volume":"45","author":"Noordhuis","year":"2020","journal-title":"Clin. Otolaryngol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.7150\/ijms.6855","article-title":"Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma","volume":"10","author":"Yan","year":"2013","journal-title":"Int. J. Med. Sci."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2273.2001.00512.x","article-title":"The expression of vascular endothelial growth factor (VEGF) and VEGF-C in early laryngeal cancer: Relationship with radioresistance","volume":"26","author":"Homer","year":"2001","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.2147\/OTT.S176818","article-title":"Inhibition of GLUT-1 expression and the PI3K\/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro","volume":"11","author":"Jiang","year":"2018","journal-title":"Onco Targets Ther."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"102460","DOI":"10.1016\/j.tranon.2025.102460","article-title":"Mitochondrial apoptosis induced by MNAT1 in laryngeal squamous cell carcinoma cells reverses drug resistance","volume":"59","author":"An","year":"2025","journal-title":"Transl. Oncol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"15941","DOI":"10.1002\/jcp.28253","article-title":"Wnt1-inducible signaling protein 1 regulates laryngeal squamous cell carcinoma glycolysis and chemoresistance via the YAP1\/TEAD1\/GLUT1 pathway","volume":"234","author":"Wang","year":"2019","journal-title":"J. Cell Physiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s10020-026-01490-9","article-title":"LARS promotes hepatocellular carcinoma progression via the PI3K\/AKT\/mTOR pathway and interaction with RPS5, and serves as a prognostic biomarker","volume":"32","author":"Chen","year":"2026","journal-title":"Mol. Med."},{"key":"ref_117","first-page":"149","article-title":"Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: Which is the optimal specimen?","volume":"17","author":"Lee","year":"2000","journal-title":"Int. J. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Niers, T.M., Richel, D.J., Meijers, J.C., and Schlingemann, R.O. (2011). Vascular endothelial growth factor in the circulation in cancer patients may not be a relevant biomarker. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019873"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-2903-1_1","article-title":"Enzyme-Linked Immunosorbent Assay: Types and Applications","volume":"2612","author":"Hayrapetyan","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ymeth.2014.01.018","article-title":"Antibody validation of immunohistochemistry for biomarker discovery: Recommendations of a consortium of academic and pharmaceutical based histopathology researchers","volume":"70","author":"Howat","year":"2014","journal-title":"Methods"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/prca.201400130","article-title":"ELISA in the multiplex era: Potentials and pitfalls","volume":"9","author":"Tighe","year":"2015","journal-title":"Proteom. Clin. Appl."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Sj\u00f6bom, U., Nilsson, A.K., Gyllensten, H., Hellstr\u00f6m, A., and L\u00f6fqvist, C. (2022). A systematic review and meta-analysis of preanalytical factors and methodological differences influencing the measurement of circulating vascular endothelial growth factor. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0270232"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/bjc.1998.158","article-title":"Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology","volume":"77","author":"Banks","year":"1998","journal-title":"Br. J. Cancer"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1164\/ajrccm.161.6.9905022","article-title":"Serum vascular endothelial growth factor is elevated in cystic fibrosis and decreases with treatment of acute pulmonary exacerbation","volume":"161","author":"McColley","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00109-020-01874-2","article-title":"Clinical implications of intratumor heterogeneity: Challenges and opportunities","volume":"98","author":"Cajal","year":"2020","journal-title":"J. Mol. Med."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjc.6602678","article-title":"Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics. REporting recommendations for tumour MARKer prognostic studies (REMARK)","volume":"93","author":"McShane","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_127","first-page":"1629","article-title":"Design of clinical trials for biomarker research in oncology","volume":"1","author":"Mandrekar","year":"2011","journal-title":"Clin. Investig."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Cabezas-Camarero, S., and P\u00e9rez-Segura, P. (2022). Liquid Biopsy in Head and Neck Cancer: Current Evidence and Future Perspective on Squamous Cell, Salivary Gland, Paranasal Sinus and Nasopharyngeal Cancers. Cancers, 14.","DOI":"10.3390\/cancers14122858"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Chen, B., Leung, L.L., Qu, X., and Chan, J.Y. (2023). Extracellular Vesicles as Biomarkers in Head and Neck Squamous Cell Carcinoma: From Diagnosis to Disease-Free Survival. Cancers, 15.","DOI":"10.3390\/cancers15061826"},{"key":"ref_130","first-page":"120","article-title":"The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation","volume":"33","author":"Grosu","year":"2022","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00259-016-3429-y","article-title":"Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer","volume":"43","author":"Zegers","year":"2016","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/9\/2103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:19:00Z","timestamp":1789989540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/9\/2103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":131,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["biomedicines14092103"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14092103","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}